China Pharma Holdings, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2017 | — | $58.4M | $2.5M |
| Jun 2017 | $10.2M | $57.1M | $1.7M |
| Sep 2017 | $9.2M | $57.0M | $1.1M |
| Dec 2017 | $9.2M | $43.1M | $2.0M |
| Mar 2018 | $9.4M | $44.5M | $2.5M |
| Jun 2018 | $8.9M | $41.0M | $1.9M |
| Sep 2018 | $6.6M | $37.6M | $667.6K |
| Dec 2018 | $6.5M | $30.2M | $1.2M |
| Mar 2019 | $6.6M | $30.6M | $961.3K |
| Jun 2019 | $6.4M | $29.0M | $1.7M |
| Sep 2019 | $4.2M | $27.4M | $761.6K |
| Dec 2019 | $4.3M | $9.2M | $1.1M |
| Mar 2020 | $4.1M | $8.4M | $145.9K |
| Jun 2020 | $6.0M | $8.4M | $1.8M |
| Sep 2020 | $5.0M | $7.9M | $346.6K |
| Dec 2020 | $5.2M | $8.0M | $957.7K |
| Mar 2021 | $5.0M | $7.2M | $534.5K |
| Jun 2021 | $5.0M | $6.5M | $1.8M |
| Sep 2021 | $4.3M | $6.9M | $458.8K |
| Dec 2021 | — | $6.0M | $4.9M |
| Mar 2022 | — | $5.3M | $3.7M |
| Jun 2022 | — | $4.0M | $2.2M |
| Sep 2022 | — | $2.8M | $2.1M |
| Dec 2022 | — | $4.3M | $2.0M |
| Mar 2023 | — | $4.7M | $1.2M |
| Jun 2023 | — | $4.4M | $901.9K |
| Sep 2023 | — | $6.1M | $1.4M |
| Dec 2023 | — | $7.5M | $1.4M |
| Mar 2024 | — | $8.3M | $838.9K |
| Jun 2024 | — | $7.4M | $739.3K |
| Sep 2024 | — | $6.5M | $700.0K |
| Dec 2024 | — | $7.7M | $626.9K |
| Mar 2025 | — | $7.0M | $400.0K |
| Jun 2025 | — | $6.5M | $600.0K |
| Sep 2025 | — | $8.3M | $267.6K |
| Dec 2025 | — | $22.7M | $345.1K |
| Mar 2026 | — | $37.0M | $168.5K |
| Jun 2026 | — | $36.2M | $304.9K |